Cardiovascular Systems, Inc. (CSII) — Financial statements
Income statement, balance sheet, and cash flow for Cardiovascular Systems, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 236↓8.8% | 259↑9.5% | 237↓4.6% | 248↑14.3% | 217 | |
| Cost of Revenue | 63↑3.8% | 61↑25.4% | 49↑2.3% | 48↑20.8% | 39 | |
| Gross Profit | 173↓12.7% | 198↑5.4% | 188↓6.3% | 200↑12.8% | 178 | |
| Operating Expenses | ||||||
| R&D Expenses | 37↓10.6% | 41↓5.3% | 43↑29.6% | 33↑25.1% | 27 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↓100.0% | 168↑12.9% | 149 | |
| SG&A Expenses | 171↑1.8% | 167↓1.5% | 170↑1.4% | 168↑12.9% | 149 | |
| Other Expenses | 1↑10.4% | 1↓1.5% | 1↑62.4% | 0.76↑294.9% | -0.39 | |
| Operating Expenses | 209↓0.6% | 210↓2.2% | 215↑6.7% | 201↑14.7% | 175 | |
| Total Costs & Expenses | 272↑0.4% | 271↑2.9% | 263↑5.8% | 249↑15.8% | 215 | |
| Operating Results | ||||||
| Operating Income | -36↓200.1% | -12↑55.4% | -27↓3145.1% | -0.83↑51.5% | -2 | |
| Depreciation & Amortization | 1↑10.4% | 1↓1.5% | 1↓64.2% | 3↓12.4% | 4 | |
| EBITDA | -34↓229.3% | -10↑57.1% | -24↓569.9% | 5↑126.7% | 2 | |
| EBIT | -35↓206.0% | -11↑54.3% | -25↓1646.1% | 2↑534.0% | -0.37 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.82↑33.9% | -1↓430.5% | -0.23↓130.7% | 0.76↑294.9% | -0.39 | |
| Interest Income | 0.82↑63.7% | 0.50↓71.3% | 2↓28.8% | 2↑84.2% | 1 | |
| Interest Expense | 2↓5.8% | 2↓12.1% | 2↑17.2% | 2↓1.9% | 2 | |
| Non-Operating Income | -0.82↓63.7% | -0.50↑71.3% | -2↑28.8% | -2↓84.2% | -1 | |
| Other Income / Expenses | -0.82↑33.9% | -1↓430.5% | -0.23↓130.7% | 0.76↓78.6% | 4 | |
| Income Before Tax | -37↓178.1% | -13↑51.2% | -27↓41446.2% | -0.07↓103.5% | 2 | |
| Income Tax Expense | 0.31↑23.0% | 0.25↑9.1% | 0.23↑21.6% | 0.19↑43.9% | 0.13 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -37↓175.2% | -13↑50.7% | -27↓10580.8% | -0.26↓114.9% | 2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -37↓175.2% | -13↑50.7% | -27↓10580.8% | -0.26↓114.9% | 2 | |
| Bottom-Line Net Income | -37↓175.2% | -13↑50.7% | -27↓10580.8% | -0.26↓114.9% | 2 | |
| EPS (Basic) | -0.94↓168.6% | -0.35↑55.7% | -0.79↓10294.7% | -0.01↓114.9% | 0.05 | |
| EPS (Diluted) | -0.94↓168.6% | -0.35↑55.7% | -0.79↓10294.7% | -0.01↓114.9% | 0.05 | |
| Weighted Average Shares | 39↑1.0% | 39↑13.3% | 34↑2.2% | 34↑1.2% | 33 | |
| Weighted Average Diluted Shares | 39↑1.0% | 39↑13.3% | 34↑2.2% | 34↓0.2% | 34 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.